BV
Biotechnology Value Fund L.P. disclosed a 8.4% stake in XNCR
Biotechnology Value Fund L.P. reported owning 8.4% of Xencor Inc (XNCR) (6,227,034 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.